These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 9035227)

  • 1. An investigation of the representativity of neuropsychiatrists and their patients in a drug utilization observation study on fluoxetine.
    Schaaf B; Linden M; Weber HJ
    Pharmacopsychiatry; 1997 Jan; 30(1 Suppl):44-51. PubMed ID: 9035227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antidepressant drug use: differences between psychiatrists and general practitioners. Results from a drug utilization observation study with fluoxetine.
    Dittmann RW; Linden M; Osterheider M; Schaaf B; Ohnmacht U; Weber HJ
    Pharmacopsychiatry; 1997 Jan; 30(1 Suppl):28-34. PubMed ID: 9035225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluoxetine and concomitant centrally acting medication use during clinical trials of depression: the absence of an effect related to agitation and suicidal behavior.
    Wernicke JF; Sayler ME; Koke SC; Pearson DK; Tollefson GD
    Depress Anxiety; 1997; 6(1):31-9. PubMed ID: 9394873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antidepressants consumption in the global population in France].
    Olié JP; Elomari F; Spadone C; Lépine JP
    Encephale; 2002; 28(5 Pt 1):411-7. PubMed ID: 12386542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality-monitoring of psychotropic drug therapy in post-marketing surveillance. Results of a drug utilization observation (DUO) study on moclobemide.
    Laux G; Baier D
    Pharmacopsychiatry; 1997 Jan; 30(1 Suppl):21-7. PubMed ID: 9035224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of fluoxetine and doxepin in treatment of melancholia in depressed patients.
    Sandor P; Baker B; Irvine J; Dorian P; McKessok D; Mendlowitz S
    Depress Anxiety; 1998; 7(2):69-72. PubMed ID: 9614594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The treatment of depression with paroxetine in psychiatric practice in Germany: the possibilities and current limitations of drug monitoring.
    Zaninelli R; Meister W
    Pharmacopsychiatry; 1997 Jan; 30(1 Suppl):9-20. PubMed ID: 9035223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug monitoring studies as a method of analyzing response criteria.
    Lehmann E; Klieser E
    Pharmacopsychiatry; 1997 Jan; 30(1 Suppl):52-6. PubMed ID: 9035228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluoxetine in the treatment of depression in Asian (Chinese and Indian) patients in Singapore.
    Tsoi WF; Tan CT; Kok LP
    Singapore Med J; 1995 Aug; 36(4):397-9. PubMed ID: 8919155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety findings from naturalistic fluoxetine drug treatment in adolescent and young adult patients.
    Dittmann RW; Czekalla J; Hundemer HP; Linden M
    J Child Adolesc Psychopharmacol; 2000; 10(2):91-102. PubMed ID: 10933119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Fluoxetine and tricyclic antidepressants: clinical tolerance in short-term combined administration].
    Bonin B; Bertschy G; Baumann P; Francois T; Vandel P; Vandel S; Sechter D; Bizouard P
    Encephale; 1996; 22(3):221-7. PubMed ID: 8767051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapy of post-stroke depression with fluoxetine. A pilot project].
    Stamenkovic M; Schindler S; Kasper S
    Nervenarzt; 1996 Jan; 67(1):62-7. PubMed ID: 8676990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder.
    Fava M; McCall WV; Krystal A; Wessel T; Rubens R; Caron J; Amato D; Roth T
    Biol Psychiatry; 2006 Jun; 59(11):1052-60. PubMed ID: 16581036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morning fluoxetine plus evening mianserin versus morning fluoxetine plus evening placebo in the acute treatment of major depression.
    Dam J; Ryde L; Svejsø J; Lauge N; Lauritsen B; Bech P
    Pharmacopsychiatry; 1998 Mar; 31(2):48-54. PubMed ID: 9562208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suicidality and fluoxetine: is there a relationship?
    Fava M; Rosenbaum JF
    J Clin Psychiatry; 1991 Mar; 52(3):108-11. PubMed ID: 2005073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of serotonin-related genes in antidepressant response.
    Peters EJ; Slager SL; McGrath PJ; Knowles JA; Hamilton SP
    Mol Psychiatry; 2004 Sep; 9(9):879-89. PubMed ID: 15052272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluoxetine versus moclobemide: cross-comparison between the time courses of improvement.
    Stassen HH; Angst J; Delini-Stula A
    Pharmacopsychiatry; 1999 Mar; 32(2):56-60. PubMed ID: 10333163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pattern of usage of new antidepressants in clinical practice].
    Montejo AL; Gilaberte I; Fombellida C; Hylan TR; Sacristán JA
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1998; 26(2):75-81. PubMed ID: 9595820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Moclobemide versus fluoxetine in the treatment of major depressive disorder in adults.
    Lapierre YD; Joffe R; McKenna K; Bland R; Kennedy S; Ingram P; Reesal R; Rickhi BG; Beauclair L; Chouinard G; Annable L
    J Psychiatry Neurosci; 1997 Mar; 22(2):118-26. PubMed ID: 9074306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Open trial study of a combined antidepressant (amitryptiline, perphenazine, diazepam) versus fluoxetine or imipramine in ambulatory depressed patients.
    Diaz A; Fouilloux C; Ortiz S
    Proc West Pharmacol Soc; 2002; 45():154-5. PubMed ID: 12434564
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.